IMARC Group, a leading market research company, has recently releases report titled “Gene Therapy Market Report by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide Gene, Deficiency, Growth Factors, Receptors, and Others), Vector Type (Viral Vector, Non-Viral Techniques), Delivery Method (In-Vivo Gene Therapy, Ex-Vivo Gene Therapy), Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Others), and Region 2024-2032”, Offers a comprehensive analysis of the industry, which comprises insights on the gene therapy market.

How Big Is the Gene Therapy Market?

The global gene therapy market size reached US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.8 Billion by 2032, exhibiting a growth rate (CAGR) of 13.9% during 2024-2032.

Industry Overview of Gene Therapy

Gene therapy is an advanced medical approach that involves the manipulation of genes to treat or prevent diseases at the genetic level. It corrects or replaces faulty genes responsible for causing specific diseases and treating the symptoms. It involves introducing therapeutic genetic material into the cells of the patients by directly inserting the corrected gene into the target cells or using vectors to deliver the therapeutic gene. It can treat various genetic disorders, including cystic fibrosis, sickle cell anemia, hemophilia, and muscular dystrophy.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/gene-therapy-market/requestsample

What are the growth prospects and trends in the gene therapy industry?

The surging occurrence of various chronic diseases, such as cardiovascular disorders, diabetes, thyroiditis, and obesity, represents one of the prime factors catalyzing the demand for gene therapy around the world.

Moreover, the increasing geriatric population that is more prone to developing such chronic medical conditions is favoring the growth of the market. In addition, the rising adoption of new gene therapy that offers a safer and non addictive alternative to opioids in treating various medical conditions like lower back pain and rare neuropathic pain disorders is contributing to the market growth.

Apart from this, the growing awareness about the benefits of gene therapy and easy accessibility to healthcare facilities is creating a favorable outlook for the market.

Leading Companies Operating in the Global Gene Therapy Industry:

• Abeona Therapeutics Inc.
• Adaptimmune Therapeutics plc
• Adverum Biotechnologies Inc.
• Amgen Inc.
• Astellas Pharma Inc.
• Biogen Inc.
• Bluebird Bio Inc.
• Mustang Bio Inc. (Fortress Biotech Inc.)
• Novartis AG
• Orchard Therapeutics plc
• UniQure N.V.
• Voyager Therapeutics Inc.

Gene Therapy Market  Report Segmentation?

The report has segmented the market into the following categories:

Breakup by Gene Type:

• Antigen
• Cytokine
• Tumor Suppressor
• Suicide Gene
• Deficiency
• Growth Factors
• Receptors
• Others

Breakup by Vector Type:

• Viral Vector
  • Adenoviruses
  • Lentiviruses
  • Retroviruses
  • Adeno-Associated Virus
  • Herpes Simplex Virus
  • Poxvirus
  • Vaccinia Virus
  • Others
• Non-Viral Techniques
  • Naked and Plasmid Vectors
  • Gene Gun
  • Electroporation
  • Lipofection
  • Others

Breakup by Delivery Method:

• In-Vivo Gene Therapy
• Ex-Vivo Gene Therapy

Breakup by Application:

• Oncological Disorders
• Rare Diseases
• Cardiovascular Diseases
• Neurological Disorders
• Infectious Disease
• Others

Breakup by Region:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163